IL144460A0 - Inhibitors for use in hemostasis and immune function - Google Patents

Inhibitors for use in hemostasis and immune function

Info

Publication number
IL144460A0
IL144460A0 IL14446000A IL14446000A IL144460A0 IL 144460 A0 IL144460 A0 IL 144460A0 IL 14446000 A IL14446000 A IL 14446000A IL 14446000 A IL14446000 A IL 14446000A IL 144460 A0 IL144460 A0 IL 144460A0
Authority
IL
Israel
Prior art keywords
hemostasis
inhibitors
immune function
related protein
complement related
Prior art date
Application number
IL14446000A
Other languages
English (en)
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of IL144460A0 publication Critical patent/IL144460A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14446000A 1999-02-19 2000-02-17 Inhibitors for use in hemostasis and immune function IL144460A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25360499A 1999-02-19 1999-02-19
US44479499A 1999-11-22 1999-11-22
PCT/US2000/004161 WO2000048625A2 (fr) 1999-02-19 2000-02-17 Inhibiteurs utilises dans l'hemostase et la fonction immunitaire

Publications (1)

Publication Number Publication Date
IL144460A0 true IL144460A0 (en) 2002-05-23

Family

ID=26943406

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14446000A IL144460A0 (en) 1999-02-19 2000-02-17 Inhibitors for use in hemostasis and immune function

Country Status (20)

Country Link
US (1) US6448221B1 (fr)
EP (2) EP1154785B1 (fr)
JP (1) JP2002537270A (fr)
KR (1) KR20010102130A (fr)
CN (1) CN1341027A (fr)
AT (1) ATE245439T1 (fr)
AU (1) AU772103B2 (fr)
BR (1) BR0008298A (fr)
CA (1) CA2361273A1 (fr)
CZ (1) CZ20012916A3 (fr)
DE (1) DE60004015T2 (fr)
DK (1) DK1154785T3 (fr)
ES (1) ES2202061T3 (fr)
HK (1) HK1039892A1 (fr)
HU (1) HUP0105284A3 (fr)
IL (1) IL144460A0 (fr)
NO (1) NO20014012L (fr)
PL (1) PL349924A1 (fr)
PT (1) PT1154785E (fr)
WO (1) WO2000048625A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US20040014650A1 (en) * 2002-07-17 2004-01-22 Sheppard Paul D Methods for enhancing wound repair
US6544946B1 (en) * 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
MY128992A (en) * 2000-08-25 2007-03-30 Merck Patent Gmbh Saratin for inhibiting platelet adhesion to collagen
CA2424029C (fr) 2000-09-29 2008-01-29 Cordis Corporation Dispositifs medicaux enrobes
US20030220253A1 (en) * 2002-03-08 2003-11-27 Lasser Gerald W. Inhibitors for use in hemostasis
NO20035748D0 (no) * 2003-12-19 2003-12-19 Amersham Health As Optisk avbildning av sårbar arteriosklerose
RU2279853C2 (ru) * 2004-07-23 2006-07-20 Наталья Юрьевна Демидова Способ коррекции нарушений гемостаза при обширных операциях на органах гепатопанкреатодуоденальной зоны
US9471978B2 (en) 2004-10-04 2016-10-18 Banner Health Methodologies linking patterns from multi-modality datasets
US7964557B2 (en) * 2005-03-28 2011-06-21 University Of Louisville Research Foundation, Inc. Inhibition of wet type age related macular degeneration (AMD) by adiponectin or acrp 30
CA2616912A1 (fr) * 2005-07-29 2007-02-08 Laboratoires Serono S.A. Utilisation d'acrp30 pour le traitement et/ou la prevention de la thrombose et du cancer
US8686117B2 (en) 2006-12-21 2014-04-01 Jnc Corporation Platelet aggregation inducing substance
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
WO2023215294A1 (fr) * 2022-05-02 2023-11-09 The Board Of Trustees Of The Leland Stanford Junior University Inhibition de la voie du complément à des fins de cicatrisation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
EP1000084A4 (fr) 1997-07-08 2003-03-26 Human Genome Sciences Inc 123 proteines humaines secretees
HUP0003762A3 (en) * 1997-07-18 2005-11-28 Zymogenetics Inc Adipocyte-specific protein homologs
DK1000149T3 (da) 1997-08-01 2007-09-10 Serono Genetics Inst Sa 5'-EST'ere til udskilte proteiner identificeret fra hjernevæv
WO1999010492A1 (fr) 1997-08-26 1999-03-04 Zymogenetics, Inc. Homologues de proteines specifiques aux adipocytes
JP3538711B2 (ja) 1997-10-29 2004-06-14 大塚製薬株式会社 平滑筋増殖抑制組成物、動脈硬化症診断方法及びそのキット
NZ527900A (en) 1997-12-03 2005-02-25 Genentech Inc PRO361 polypeptides and nucleic acids with homology to mucin and chitinase
WO1999033979A2 (fr) 1997-12-30 1999-07-08 Chiron Corporation Proteines secretees par la moelle osseuse et polynucleotides
ID27813A (id) 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
WO1999055865A1 (fr) 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isoles de cellules de la peau et leurs procedes d'utilisation
EP1085897A4 (fr) 1998-05-21 2003-03-12 Smithkline Beecham Corp Acrp30r1l, homologue de acrp30 (proteine associee a un complement de l'adipocyte 30 kd)

Also Published As

Publication number Publication date
KR20010102130A (ko) 2001-11-15
ATE245439T1 (de) 2003-08-15
DK1154785T3 (da) 2003-11-17
EP1154785A2 (fr) 2001-11-21
AU772103B2 (en) 2004-04-08
EP1382345A2 (fr) 2004-01-21
CZ20012916A3 (cs) 2002-05-15
HUP0105284A2 (hu) 2002-05-29
DE60004015T2 (de) 2004-04-15
WO2000048625A3 (fr) 2000-12-28
HK1039892A1 (zh) 2002-05-17
JP2002537270A (ja) 2002-11-05
CN1341027A (zh) 2002-03-20
ES2202061T3 (es) 2004-04-01
PL349924A1 (en) 2002-10-21
WO2000048625A2 (fr) 2000-08-24
AU2883200A (en) 2000-09-04
HUP0105284A3 (en) 2003-12-29
US6448221B1 (en) 2002-09-10
DE60004015D1 (de) 2003-08-28
EP1154785B1 (fr) 2003-07-23
NO20014012L (no) 2001-10-02
EP1382345A3 (fr) 2004-01-28
NO20014012D0 (no) 2001-08-17
BR0008298A (pt) 2002-02-19
PT1154785E (pt) 2003-12-31
CA2361273A1 (fr) 2000-08-24

Similar Documents

Publication Publication Date Title
IL144460A0 (en) Inhibitors for use in hemostasis and immune function
WO2002074337A8 (fr) Inhibiteurs et/ou antagonistes de proteines hmgb1 destines au traitement de maladies vasculaires
AU5056196A (en) Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof
DK0913156T3 (da) Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis
IL161591A0 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
WO1995021601A3 (fr) Proteines de 'domaine de kunitz' a activite antikallikreine, et leurs analogues
WO2003008443A3 (fr) Peptides efficaces dans le traitement de tumeurs et d'autres etats pathologiques necessitant l'ablation ou la destruction de cellules
CA2181150A1 (fr) Peptides bioroniquement actifs provenant de domaines fonctionnels d'une proteine bactericide augmentant la permeabilite, et leurs utilisations
WO1992011850A3 (fr) Utilisation d'inhibiteurs de la calpaine dans l'inhibition et le traitement de la neurodegenerescence
WO1994016073A3 (fr) Procedes et reactifs permettant l'inhibition de la furine endoprotease
EP1918298A3 (fr) Peptide
BR9406720A (pt) Utilização de um adenovírus recombinante de origem animal adenovírus recombinante de origem animal e composição farmacêutica compreendendo um ou vários adenovírus
EP0651655A4 (fr) Reduction d'hemorragie microvasculaire en cours de chirurgie par blocage d'activation de proteine c.
GB9930768D0 (en) Composition
PL354961A1 (en) Prevention and treatment of diseases associated with blood coagulation
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
IL130500A0 (en) Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
ID23176A (id) Metoda untuk mengobati gangguan pembuluh darah
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
DE60139574D1 (de) Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung
DE50207168D1 (de) Kombinationspräparat zur Therapie von immunologischen Erkrankungen
GEP19991605B (en) Inhibitor, Its Obtaining and Use
UA9703A (uk) Антипротеіназний засіб
DE69626691D1 (de) Komponente b als wundheilendes mittel
EP1714979A3 (fr) Peptides servant à traiter des tumeurs ou d'autres états necessitant la suppression ou la destruction de cellules